Pre-exposure to vasopressin potentiates the vasoconstrictive effect of epinephrine in rat aorta isolated during late anaphylaxis

Shock

Volumn 33, Issue 6, 2010, Pages 655-661

  Dewachter, Pascale ^a   Emala, Charles W ^b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b Columbia University ^*  (United States)

Author keywords

Allergy; Anaesthesia; General; Muscle vascular; Rat; Responses

Indexed keywords

ADRENALIN; ARGIPRESSIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; VASOPRESSIN;

ANAPHYLAXIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA CONSTRICTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EXPOSURE; DRUG POTENTIATION; DRUG RESPONSE; DRUG SENSITIVITY; IN VITRO STUDY; NONHUMAN; RAT; VASCULAR RING; VASOCONSTRICTION;

ANAPHYLAXIS; ANIMALS; AORTA; ARGININE VASOPRESSIN; DRUG SYNERGISM; EPINEPHRINE; NG-NITROARGININE METHYL ESTER; RATS; RATS, INBRED BN; TIME FACTORS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 77952404741     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181cb93d5     Document Type: Article

References (35)

1. French Society of Anesthesiology and Intensive Care Medicine: Reducing the risk of anaphylaxis during anaesthesia. Abbreviated text. Ann Fr Anesth Reanim 21(suppl 1):7-23, 2002.
2. American Heart Association: Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care: part 10.6: anaphylaxis. Circulation 112: IV143-IV145, 2005.
3. Kroigaard M, Garvey LH, Gillberg L, Johansson SG, Mosbech H, Florvaag E, et al.: Scandinavian clinical practice guidelines on the diagnosis, management and follow-up of anaphylaxis during anaesthesia. Acta Anaesthesiol Scand 51:655-670, 2007.
4. Harper NJ, Dixon T, Dugue P, Edgar DM, Fay A, Gooi HC, et al.: Suspected anaphylactic reactions associated with anaesthesia. Anaesthesia 64:199-211, 2009.
5. Kill C, Wranze E, Wulf H: Successful treatment of severe anaphylactic shock with vasopressin. Two case reports. Int Arch Allergy Immunol 134:260-261, 2004.
6. Schummer W, Schummer C, Wippermann J, Fuchs J: Anaphylactic shock: is vasopressin the drug of choice? Anesthesiology 101:1025-1027, 2004.
7. Williams SR, Denault AY, Pellerin M, Martineau R: Vasopressin for treatment of shock following aprotinin administration. Can J Anaesth 51:169-172, 2004.
8. Hussain AM, Yousuf B, Khan MA, Khan FH, Khan FA: Vasopressin for the management of catecholamine-resistant anaphylactic shock. Singapore Med J 49:e225-e228, 2008.
9. Meng L, Williams EL: Case report: treatment of rocuronium-induced ana-phylactic shock with vasopressin. Can J Anaesth 55:437-440, 2008.
10. Schummer C, Wirsing M, Schummer W: The pivotal role of vasopressin in refractory anaphylactic shock. Anesth Analg 107:620-624, 2008.
11. Bartelstone HJ, Nasmyth PA: Vasopressin potentiation of catecholamine actions in dog, rat, cat, and rat aortic strip. Am J Physiol 208:754-762, 1965.
12. Medina P, Noguera I, Aldasoro M, Vila JM, Flor B, Lluch S: Enhancement by vasopressin of adrenergic responses in human mesenteric arteries. Am J Physiol 272:H1087-H1093, 1997.
13. Hamu Y, Kanmura Y, Tsuneyoshi I, Yoshimura N: The effects of vasopressin on endotoxin-induced attenuation of contractile responses in human gastro-epiploic arteries in vitro. Anesth Analg 88:542-548, 1999.
14. Leone M, Boyle WA: Decreased vasopressin responsiveness in vasodilatory septic shock-like conditions. Crit Care Med 34:1126-1130, 2006.
15. Tsuda A, Tanaka KA, Huraux C, Szlam F, Sato N, Yamaguchi K, et al.: The in vitro reversal of histamine-induced vasodilation in the human internal mammary artery. Anesth Analg 93:1453-1459, 2001.
16. Hiruta A, Mitsuhata H, Hiruta M, Horikawa Y, Takeuchi H, Kawakami T, et al.: Vasopressin may be useful in the treatment of systemic anaphylaxis in rabbits. Shock 24:264-269, 2005.
17. Dewachter P, Jouan-Hureaux V, Lartaud I, Bello G, de Talance N, Longrois D, et al.: Comparison of arginine vasopressin, terlipressin, or epinephrine to correct hypotension in a model of anaphylactic shock in anesthetized Brown Norway rats. Anesthesiology 104:734-741, 2006.
18. Dewachter P, Raeth-Fries I, Jouan-Hureaux V, Menu P, Vigneron C, Longrois D, et al.: A comparison of epinephrine only, arginine vasopressin only, and epinephrine followed by arginine vasopressin on the survival rate in a rat model of anaphylactic shock. Anesthesiology 106:977-983, 2007.
19. Mitsuhata H, Saitoh J, Takeuchi H, Hasome N, Horiguchi Y, Shimizu R: Production of nitric oxide in anaphylaxis in rabbits. Shock 2:381-384, 1994.
20. Cauwels A, Janssen B, Buys E, Sips P, Brouckaert P: Anaphylactic shock depends on PI3K and eNOS-derived NO. J Clin Invest 116:2244-2251, 2006.
21. Dewachter P, Jouan-Hureaux V, Franck P, Menu P, de Talance N, Zannad F, et al.: Anaphylactic shock: a form of distributive shock without inhibition of oxygen consumption. Anesthesiology 103:40-49, 2005.
22. Bellou A, Saint-Laudy J, Knippels L, Montemont C, Vauthier E, Gerard P, et al.: Brown Norway rat ovalbumin-specific immunoglobulin E antibodies increase the human basophil expression of CD63 marker. Scand J Immunol 57:271-278, 2003.
23. Shibamoto T, Cui S, Ruan Z, Liu W, Takano H, Kurata Y: Hepatic veno-constriction is involved in anaphylactic hypotension in rats. Am J Physiol Heart Circ Physiol 289:H1436-H1444, 2005.
24. Noguera I, Medina P, Segarra G, Martinez MC, Aldasoro M, Vila JM, et al.: Potentiation by vasopressin of adrenergic vasoconstriction in the rat isolated mesenteric artery. Br J Pharmacol 122:431-438, 1997.
25. Hollenberg SM, Cunnion RE, Zimmerberg J: Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to catecholamines in septic rats. Am J Physiol 264(2 Pt 2):H660-H663, 1993.
26. Thiemermann C, Szabo C, Mitchell JA, Vane JR: Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc Natl Acad Sci USA 90:267-271, 1993.
27. Landry DW, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med 345:588-595, 2001.
28. Barrett LK, Singer M, Clapp LH: Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med 35:33-40, 2007.
29. 1-receptor in cultured rat mesangial cells. Am J Physiol 276(3 Pt 2):F433-F441, 1999.
30. Bartho L, Koczan G, Petho G, Maggi CA: Blockade of nitric oxide synthase inhibits nerve-mediated contraction in the rat small intestine. Neurosci Lett 145:43-46, 1992.
31. Yamato S, Spechler SJ, Goyal RK: Role of nitric oxide in esophageal peristalsis in the opossum. Gastroenterology 103:197-204, 1992.
32. Ward SM, Dalziel HH, Thornbury KD, Westfall DP, Sanders KM: Non-adrenergic, non-cholinergic hyperpolarization in rebound excitation in GI muscles are mediated by nitric oxide. Am J Physiol 262:G237-G243, 1992.
33. Saha JK, Hirano I, Goyal RK: Nitric oxide mediated contraction of the opossum esophageal longitudinal muscle: mechanism of action. Gastroenter-ology 104:A574, 1993.
34. Vladimirova I, Jurkiewicz NH, Jurkiewicz A: Evidence for participation of nitric oxide in excitatory neurotransmission in rat vas deferens. Life Sci 55: 1123-1128, 1994.
35. Lefebvre RA, Bartho L: Mechanism of nitric oxide-induced contraction in the rat isolated small intestine. Br J Pharmacol 120:975-981, 1997.